1[1]Yokoyama A.Current status and future directions of gemcitabine in the treatment of non-small-cell lung cancer and pancreatic cancer[J].Gan To Kagaku Ryoho,2000,27(8):1294-1300. 被引量：1
2[2]Manegold C, Zatloukal P, Krejcy K, et al. Gemcitabine in non-small-cell lung cancer (NSCLC)[J].Invest New Drugs,2000,18(1):29-42. 被引量：1
3[3]Merimsky O, Wigler N, Greif Y, et al. Monthly gemcitabine (days 1, 8 and 15) plus cisplatin (days 1-3) in advanced non-small-cell lung cancer: a phase Ⅱ study[J].Anticancer Drugs,2000,11(2):117-121. 被引量：1
3Mazzanti P, Massacesi C, Rocchi ML, et al. Randomized, muhicenter, Phase II study of gemcitabine plus cisplatin versus gemehabine plus carboplatin in patients with advanced non-small-cell lung cancer. Lung Cancer,2003,41 ( 1 ) :81 - 89. 被引量：1
4Soto Parra HJ, Cavina R, Autonolli G, et al. Superiority of three week vs four week schedule of cisplatin (CDDP) and gemcitabine ( GEM ) : resuits of a randomized phase II study. Lung Cancer, 2000,29 ( Suppl 1) :48 -50. 被引量：1
5Gandara DK, Lau DH, Lara PN Jr, et al. Gemcitabine/carboplatin combination regimens : importance of dose schedule. Oncology, 2000,14 ( 7 Suppl 4) :26 - 30. 被引量：1
6Mazzanti P,Massacesi C,Rocchi ML,et al.Randomized,multicenter,Ph-ase Ⅱ study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer[J].Lung Cancer,2003,41(1):81～89 被引量：1
7Soto Parra HJ,Cavina R,Autonolli G,et al.Superiority of three week vs four week schedule of cisplatin (CDDP) and gemcitabine (GEM):results of a randomized phase Ⅱ study[J].Lung Cancer,2000,29(Suppl 1):48～50 被引量：1
9Kikuchi A,Holan V,Minowada J.Effects of tumor necrosis factor alpha,interferon alpha and interferon gamma on non lymphoid leukemia cell lines:growth inhibition,differentiation induction and drug sensitivity modulation Cancer Immunol Immunother,1992,35:257 被引量：1
10Borsellino N,Crescimanno M,Flandian C,et al.Combined activity of interleukin-1 alpha or TNF-alpha and doxorubicin on multidrug resistant cell lines evidence that TNF and DXR have synergistic antitumor and differntiation inducing effects.Anticancer Res,1994,14:2643 被引量：1
